A1cNow, the first handheld monitor for testing glycosylated hemoglobin (HbA1c)
June 2001
There's lots of excitement about A1cNow, the first handheld monitor for testing glycosylated hemoglobin (HbA1c).
Experts put a lot of emphasis on monitoring glycosylated hemoglobin. Using HbA1c to get a 2 to 3 month picture of glycemic control helps determine appropriate therapy.
The Amer Diabetes Assoc recommends shooting for an HbA1c < 7%.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote